12 CRA consultants named top IP professionals in the 2022 IAM Patent 1000
12 CRA consultants were recognized as leading patent professionals by Intellectual Asset Management (IAM). The IAM Patent 1000: The World’s Leading Patent...
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Engagements
- 01High-profile US patent litigation regarding HIV medicationsCRA was retained by plaintiffs ViiV Healthcare and other companies in their high-profile US patent litigation against Gilead Sciences, Inc., regarding HIV...View engagement
- 02CRA opines on irreparable harm at Delaware Chancery CourtIn a matter before the Delaware Chancery Court, CRA was retained by an early-stage pharmaceutical manufacturer whose trade secrets had been misappropriated...View engagement
- 03CRA addressed a claim that a company had improperly failed to pay required development milestones upon termination of a drug development programIn litigation before the Delaware Court of Chancery, a CRA expert was asked to address the basis for a company’s decision to terminate the development of a...View engagement
Meet our team
![Gregory Bell | Expert Witness | Charles River Associates]()
Gregory K. BellGroup Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.com![Peter Rankin Life Sciences Litigation Charles River Associates]()
![Andrew Tepperman | Life Sciences Litigation | Charles River Associates]()
Latest insights
Recent events
Licensing Executives Society 2021 Royalty Rates & Deal Terms Survey Presentation
Sean Sheridan co-presents an overview of the Licensing Executives Society 2021 Royalty Rates & Deal Terms Survey with LES during a private BIO International...
Knowledge Group: What’s New for Hatch-Waxman Litigation: Exploring Trends, Updates, and Critical Issues
Sean Sheridan is a speaker during the session. For more information on this event, click here.